Cytomegalovirus in the setting of infection with human immunodeficiency virus

Reviews of Infectious Diseases

Volumn 12, Issue , 1990, Pages S811-S819

  Schooley, Robert T ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; INTERFERON; INTERLEUKIN 2; METHISOPRINOL; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AZOOSPERMIA; BLOOD TOXICITY; CONFERENCE PAPER; CYTOMEGALOVIRUS; DRUG EFFICACY; ENCEPHALITIS; GASTROENTERITIS; GASTROINTESTINAL DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; RETINITIS; THROMBOPHLEBITIS; VIRUS EXCRETION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS REPLICATION;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HIV; HIV INFECTIONS; HUMAN; PREVALENCE;

EID: 0025045289     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/12.Supplement_7.S811     Document Type: Article

References (87)

1. Nakamura S, Salahuddin SZ, Biberfeld P, Ensoli B, Markham PD, Wong-Staal F, Gallo RC. Kaposi’s sarcoma cells: long-term culture with growth factor from retrovirus- infected CD4+ T cells. Science 1988;242:426–30
2. Salahuddin SZ, Nakamura S, Biberfeld P, Kaplan MH, Markham PD, Larsson L, Gallo RC. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 1988;242:430–3
3. Drew WL, Mintz L, Miner RC, Sands M, Ketterer B. Prevalence of cytomegalovirus infection in homosexual men. J Infect Dis 1981;143:188–92
4. Quinnan GV, Masur H, Rook AH, Armstrong G, Frederick WR, Epstein J, Manischewitz JF, Macher AM, Jackson L, Ames J, Smith HA, Parker M, Pearson GR, Parrillo J, Mitchell C, Straus SE. Herpesvirus infections in the acquired immune deficiency syndrome. JAMA 1984;252:72–7
5. Lange M, Klein EB, Kornfield H, Cooper LZ, Grieco MH. Cytomegalovirus isolation from healthy homosexual men. JAMA 1984;252:1908–10
6. Collier AC, Meyers JD, Corey L, Murphy VL, Roberts PL, Handsfield HH. Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity. Am J Med 1987;82:593–601
7. Quinn TC, Piot P, McCormiek JB, Feinsod FM, Taelman H, Kapita B, Stevens W, Fauci AS. Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA 1987;257:2617–21
8. Sullivan JL, Brewster FE, Brettler DB, Forsberg AD, Cheeseman SH, Byron KS, Baker SM, Willitts DL, Lew RA, Levine PH. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses. J Pediatr 1986;108:504–10
9. Drew WL, Sweet ES, Miner RC, Mocarski ES. Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. J Infect Dis 1984;150:952–3
10. Quinnan GV, Siegel JP, Epstein JS, Manischewitz JF, Barnes S, Wells MA. Mechanisms of T-cell functional deficiency in the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:710–4
11. Rook AH, Manischewitz JF, Frederick WR, Epstein JS, Jackson L, Gelmann E, Steis R, Masur H, Quinnan GV Jr. Deficient, HLA-restricted, cytomegalovirus-specific cytotoxic T cells and natural killer cells in patients with the acquired immunodeficiency syndrome. J Infect Dis 1985; 152:627–30
12. Epstein JS, Frederick WR, Rook AH, Jackson L, Manischewitz JF, Mayner RE, Masur H, Enterline JC, Djeu JY, Quinnan GV Jr. Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome. J Infect Dis 1985;152:727–33
13. Blumberg RS, Paradis T, Byington R, Henle W, Hirsch MS, Schooley RT. Effects of human immunodeficiency virus on the cellular immune response to Epstein-Barr virus in homosexual men: characterization of the cytotoxic response and lymphokine production. J Infect Dis 1987;155:877–90
14. Rook AH, Masur H, Lane HC, Frederick W, Kasahara T, Macher AM, Djeu JY, Manischewitz JF, Jackson L, Fauci AS, Quinnan GV Jr. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest 1983;72:398–403
15. Rinaldo CR Jr, Carney WP, Richter BS, Black PH, Hirsch MS. Mechanisms of immunosuppression in cytomegalovirus mononucleosis. J Infect Dis 1980;141:488–95
16. Carney WP, Rubin RH, Hoffman RA, Hansen WP, Healey K, Hirsch MS. Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. J Immunol 1981;126:2114–6
17. Reinherz EL, O’Brien C, Rosenthal P, Schlossman SF. The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies. J Immunol 1980;125:1269–74
18. Schooley RT, Hirsch MS, Colvin RB, Cosimi AB, TolkoffRubin NE, McCluskey RT, Burton RC, Russell PS, Herrin JT, Delmonico FL, Giorgi JV, Henle W, Rubin RH. Association of herpesvirus infections with T-lymphocyte- subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med 1983; 308:307–13
19. Sodroski J, Rosen C, Wong-Staal F, Salahuddin SZ, Popovic M, Arya S, Gallo RC, Haseltine WA. 7hjns-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science 1985;227:171–3
20. Arya SK, Guo C, Josephs SF, Wong-Staal F. 7rans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 1985;229:69–73
21. Sodroski J, Goh WC, Rosen C, Dayton A, Terwilliger E, Haseltine W. A second post-tianscriptional frans-activator gene required for HTLV-III replication. Nature 1986;321: 412–7
22. Knight DM, Flomerfelt FA, Ghrayeb J. Expression of the art/trs protein of HIV and study of its role in viral envelope synthesis. Science 1987;236:837–40
23. Jones KA, Kadonaga JT, Luciw PA, Tjian R. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Spl. Science 1986;232:755–9
24. Nabel G, Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 1987;326:711–3
25. Zagury D, Bernard J, Leonard R, Cheynier R, Feldman M, Sarin PS, Gallo RC. Long-term cultures of HTLV-III- infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science 1986;231:850–3
26. Mosca JD, Bednarik DP, Raj NBK, Rosen CA, Sodroski JG, Haseltine WA, Pitha PM. Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature 1987;325:67–70
27. Gendelman HE, Phelps W, Feigenbaum L, Ostrove JM, Adachi A, Howley PM, Khoury G, Ginsberg HS, Martin M A. 7hwis-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci USA 1986;83:9759–63
28. Skolnik PR, Kosloff BR, Hirsch MS. Bidirectional interactions between human immunodeficiency virus type I and cytomegalovirus. J Infect Dis 1988;157:508–14
29. Montagnier L, Gruest J, Chamaret S, Dauguet C, Axler C, Guetard D, Nugeyre MT, Barre-Sinoussi F, Chermann JC, Brunet JB, Klatzmann D, Gluckman JC. Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. Science 1984;225:63–6
30. Blumberg RS, Paradis TJ, Crawford D, Byington RE, Hirsch MS, Schooley RT. Effects of human immunodeficiency virus (HIV) on the cytotoxic response to Epstein-Barr virus (EBV) transformed B lymphocytes. AIDS Res Hum Retroviruses 1987;3:303–15
31. Nelson JA, Reynolds-Kohler C, Oldstone M.B.A., Wiley CA. HIV and HCMV coinfect brain cells in patients with AIDS. Virology 1988;165:286–90
32. Polk BF, Fox R, Brookmeyer R, Kanchanaraksa S, Kaslow R, Visscher B, Rinaldo C, Phair J. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987; 316:61–6
33. Lerner CW, Tapper ML. Opportunistic infection complicating acquired immune deficiency syndrome. Clinical features of 25 cases. Medicine (Baltimore) 1984;63:155–64
34. Macher AM, Reichert CM, Straus SE, Longo DL, Parrillo J, Lane HC, Fauci AS, Rook AH, Manischewitz JF, Quin- nan GV Jr. Death in the AIDS patient: role of cytomegalovirus [letter]. N Engl J Med 1983;309:1454
35. Jacobson MA, Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988;108:585–94
36. Holland GN, Gottlieb MS, Yee RD, Schanker HM, Pettit TH. Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome. Am J Ophthalmol 1982; 93:393–402
37. Friedman AH, Orellana J, Freeman WR, Luntz MH, Starr MB, Tapper ML, Spigland I, Rotterdam H, Mesa Tejada R, Braunhut S, Mildvan D, Mathur U. Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS). Br J Ophthalmol 1983;67:372–80
38. Xanas RJ, Jensen JL, Abrams AM, Wuerker RB. Oral mucosal cytomegalovirus as a manifestation of the acquired immune deficiency syndrome. Oral Surg Oral Med Oral Pathol 1987;64:183–9
39. Gertler SL, Pressman J, Price P, Brozinsky S, Miyai K. Gastrointestinal cytomegalovirus infection in a homosexual man with severe acquired immunodeficiency syndrome. Gastroenterology 1983;85:1403–6
40. Levine MS, Woldenberg R, Herlinger H, Laufer I. Opportunistic esophagitis in AIDS: radiographic diagnosis. Radiology 1987;165:815–20
41. Villar LA, Massanari RM, Mitros FA. Cytomegalovirus infection with acute erosive esophagitis. Am J Med 1984;76: 924–8
42. Elta G, TVirnage R, Eckhauser FE, Agha F, Ross S. A submucosal antral mass caused by cytomegalovirus infection in a patient with acquired immunodeficiency syndrome. Am J Gastroenterol 1986;81:714–7
43. Victoria MS, Nangia BS, Jindrak K. Cytomegalovirus pyloric obstruction in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis 1985;4:550–2
44. Kavin H, Jonas RB, Chowdhury L, Kabins S. Acalculous cholecystitis and cytomegalovirus infection in the acquired immunodeficiency syndrome. Ann Intern Med 1986;104: 53–4
45. Hinnant KL, Rotterdam HZ, Bell ET, Tipper ML. Cytomegalovirus infection of the alimentary tract: a clinicopatho- logical correlation. Am J Gastroenterol 1986;81:944–50
46. Aaron JS, Wynter CD, Kirton OC, Simko V. Cytomegalovirus associated with acalculous cholecystitis in a patient with acquired immune deficiency syndrome. Am J Gastroenterol 1988;83:879–81
47. Agha FP, Nostrant TT, Abrams GD, Mazanec M, Van Moll L, Gumucio JJ. Cytomegalovirus cholangitis in a homosexual man with acquired immune deficiency syndrome. Am J Gastroenterol 1986;81:1068–72
48. Schneiderman DJ, Cello JP, Laing FC. Papillary stenosis and sclerosing cholangitis in the acquired immunodeficiency syndrome. Ann Intern Med 1987;106:546–9
49. Blumberg RS, Kelsey P, Perrone T, Dickersin R, Laquaglia M, Ferruci J. Cytomegalovirus- and cryptosporidium- associated acalculous gangrenous cholecystis. Am J Med 1984;76:1118–23
50. Burke G, Nichols L, Balogh K, Hammer S, Jensen W, Pomposelli F, Jenkins R. Perforation of the terminal ileum with cytomegalovirus vasculitis and Kaposi’s sarcoma in a patient with acquired immunodeficiency syndrome. Surgery 1987;102:540–5
51. Rabinowitz M, Bassan I, Robinson MJ. Sexually transmitted cytomegalovirus proctitis in a woman. Am J Gastroenterol 1988;83:885–7
52. Wallace JM, Hannah J. Cytomegalovirus pneumonitis in patients with AIDS. Chest 1987;92:198–203
53. Peterson P, Stahl-Bayliss CM. Cytomegalovirus thrombophlebitis after successful DHPG therapy [letter]. Ann Intern Med 1987;106:632–3
54. Randazzo RF, Hulette CM, Gottlieb MS, Rajfer J. Cytomegaloviral epididymitis in a patient with the acquired immune deficiency syndrome. J Urol 1986;136:1095–7
55. Brown S, Senekjian EK, Montag AG. Cytomegalovirus infection of the uterine cervix in a patient with acquired immunodeficiency syndrome. Obstet Gynecol 1988;71:489–91
56. Morgello S, Cho ES, Nielson S, Devinsky O, Petito CK. Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature. Hum Pathol 1987;18:289–97
57. Hicker T, Dix RD, Katzen C, Davis RL, Schmidley JW. Cytomegalovirus and herpes simplex virus ascending myelitis in a patient with acquired immune deficiency syndrome. Ann Neurol 1985;18:74–9
58. Belman AL, Ultmann MH, Horoupian D, Novick B, Spiro AJ, Rubinstein A, Kurtzberg D, Cone-Wesson B. Neurological complications in infants and children with acquired immune deficiency syndrome. Ann Neurol 1985;18:560–6
59. Dix RD, Bredesen DE, Erlich KS, Mills J. Recovery of herpesviruses from cerebrospinal fluid of immunodeficient homosexual men. Ann Neurol 1985;18:611–4
60. Masdeu JC, Small CB, Weiss L, Elkin CM, Llena J, MesaTejada R. Multifocal cytomegalovirus encephalitis in AIDS. Ann Neurol 1988;23:97–9
61. Jeantils V, Lemaitre MO, Robert J, Gaudouen Y, Krivitzky Delzant G. Subacute polyneuropathy with encephalopathy in AIDS with human cytomegalovirus pathogenicity? Lancet 1986;1:1039
62. Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, Price RW, Navia BA, Petito CK, O’Hara CJ, Groop- man JE, Cho ES, Oleske JM, Wong-Staal F, Gallo RCHTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1985;227:177–82
63. Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985;313:1493–7
64. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089–93
65. Gabuzda DH, Ho DD, de la Monte SM, Hirsch MS, Rota TR, Sobel RA. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 1986;20:289–95
66. Reichert CM, O’Leary TJ, Levens DL, Simrell CR, Macher AM. Autopsy pathology in the acquired immune deficiency syndrome. Am J Pathol 1983;112:357–82
67. Tapper ML, Rotterdam HZ, Lerner CW, Al’Khafaji K, Seitzman PA. Adrenal necrosis in the acquired immunodeficiency syndrome. Ann Intern Med 1984;100:239–41
68. Greene LW, Cole W, Greene JB, Levy B, Louie E, Raphael Waitkevicz J, Blum M. Adrenal insufficiency as a complication of the acquired immunodeficiency syndrome. Ann Intern Med 1984;101:497–8
69. Chou S, Dylewski JS, Gaynon MW, Egbert PR, Merigan TC. Alpha-interferon administration in cytomegalovirus retinitis. Antimicrob Agents Chemother 1984;25:25–8
70. Meyers JD, McGuffin RW, Bryson YJ, Cantell K, Thomas ED. Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J Infect Dis 1982;146:80–4
71. Meyers JD, McGuffin RW, Neiman PE, Singer JW, Thomas ED. Toxicity and efficacy of human leukocyte interferon for treatment of cytomegalovirus pneumonia after marrow transplantation. J Infect Dis 1980;141:555–62
72. Felsenstein D, D’Amico DJ, Hirsch MS, Neumeyer DA, Cederberg DM, de Miranda P, Schooley RT. H-eatment of cytomegalovirus retinitis with 9-[2-hydroxy-l-(hydroxymethyl)- ethoxymethyl] guanine. Ann Intern Med 1985;103:377–80
73. Bach MC, Bagwell SP, Knapp NP, Davis KM, Hedstrom PS.9-(l,3-dihydroxy-2-propoxymethyl)guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:381–2
74. Collaborative DHPG Treatment Study Group. Treatment of serious cytomegalovirus infections with 9-(l,3-dihydroxy- 2-propoxymethyl) guanine in patients with AIDS and other immunodeficiencies. N Engl J Med 1986;314:801–5
75. D’Amico DJ, Talamo JH, Felsenstein D, Hirsch MS, Albert DM, Schooley RT. Ophthalmoscopic and histologic findings in cytomegalovirus retinitis treated with BW-B759U. Arch Ophthalmol 1986;104:1788–93
76. Masur H, Lane HC, Palestine A, Smith PD, Manischewitz J, Stevens G, Fujikawa L, Macher AM, Nussenblatt R, Baird B, Megill M, Wittek A, Quinnan GV, Parrillo JE, Rook A, Eron LJ, Poretz DM, Goldenberg RI, Fauci AS, Gelmann EP. Effect of 9-(l,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight im- munosuppressed homosexual men. Ann Intern Med 1986; 104:41–4
77. Laskin OL, Cederberg DM, Mills J, Eron LJ, Mildvan D, Spector SA, Ganciclovir Study Group. Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus. Am J Med 1987;83:201–7
78. Chachoua A, Dieterich D, Krasinski K, Greene J, Laubenstein L, Wernz J, Buhles W, Koretz S. 9-(l,3-dihydroxy-2- propoxymethyl) guanine (ganciclovir) in the treatment of cytomegalovirus gastrointestinal disease with the acquired immunodeficiency syndrome. Ann Intern Med 1987;107: 133–7
79. Bach MC. Breakthrough of cytomegalovirus infection despite 9-(l,3-dihydroxy-2-propoxymethyl) guanine therapy [letter], Ann Intern Med 1986;104:587
80. Cantrill HL, Henry K, Melroe NH, Knobloch WH, Ramsay RC, Balfour HH Jr. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir: long-term results. Ophthalmology 1989;96:367–74
81. Jacobson MA, de Miranda P, Cederberg DM, Burnette T, Cobb E, Brodie HR, Mills J. Human pharmacokinetics and tolerance of oral ganciclovir. Antimicrob Agents Chemother 1987;31:1251–4
82. Debs RJ, Montgomery AB, Brunette EN, DeBruin M, Shanley JD. Aerosol administration of antiviral agents to treat lung infection due to murine cytomegalovirus. J Infect Dis 1988;157:327–31
83. Erice A, Chou S, Biron KK, Stanat SC, Balfour HH Jr, Jordan MC. Progressive disease due to ganciclovir-resistant cytomegalvirus in immunocompromised patients. N Engl J Med 1989;320:289–93
84. Singer DRJ, Fallon TJ, Schulenburg WE, Williams G, Cohen J. Foscarnet for cytomegalovirus retinitis [letter]. Ann Intern Med 1985:103:962
85. Walmsley SL, Chew E, Read SE, Vellend H, Salit I, Rachlis A, Fanning MM. Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (foscarnet). J Infect Dis 1988;157:569–72
86. Sjovall J, Karlsson A, Ogenstad S, Sandstrom E, Saarimaki M. Pharmacokinetics and absorption of foscarnet after intravenous and oral administration to patients with human immunodeficiency virus. Clin Pharmacol Ther 1988; 44:65–73
87. Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, Jackson GG, Durack DT, King D, AZT Collaborative Working Group. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind placebo- controlled trial. N Engl J Med 1987;317:185–91